GERN实时信号 | 通过Getagraph.com最大化利润

出售 69 min ago

@ $4.07

发出时间: 29 Apr 2024 @ 23:16

回报率: 2.83%

上一信号: Feb 15 - 02:33

上一信号: 购买

回报率: 92.89 %

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 00:25):

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies...

Stats
今日成交量	12.26M
平均成交量	12.95M
市值	2.46B
EPS	$0 ( 2024-02-28 )
下一个收益日期	( $-0.100 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-13.08
ATR14	$0.0240 (0.57%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-14	Feller Faye	Buy	750 000	Employee Stock Option (Right to Buy)
2024-02-14	Kapur Anil	Buy	750 000	Employee Stock Option (Right to Buy)
2024-02-14	Samuels Scott Alan	Buy	850 000	Employee Stock Option (Right to Buy)
2024-02-14	Robertson Michelle	Buy	850 000	Employee Stock Option (Right to Buy)
2024-02-14	Grethlein Andrew J	Buy	1 200 000	Employee Stock Option (Right to Buy)

INSIDER POWER
80.32
Last 95 transactions
Buy: 25 935 774 \| Sell: 3 922 187

音量相关性

長: 0.22 (neutral)

短: 0.08 (neutral)

Signal:(39.418) Neutral

Geron Corp 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Geron Corp 相关性 - 货币/商品

0.32
( neutral )

0.31
( neutral )

0.00
( neutral )

0.76
( moderate )

0.89
( strong )

-0.63
( weak negative )

Geron Corp 财务报表

Annual	2023
营收:	$237 000
毛利润:	$-795 999 (-335.86 %)
EPS:	$-0.320

FY	2023
营收:	$237 000
毛利润:	$-795 999 (-335.86 %)
EPS:	$-0.320

FY	2022
营收:	$596 000
毛利润:	$-272 000 (-45.64 %)
EPS:	$-0.370

FY	2021
营收:	$1.39M
毛利润:	$0.00 (0.00 %)
EPS:	$-0.350

Financial Reports:

No articles found.

Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

实时更新： Geron Corp [GERN]

Upcoming Earnings Alert